Direct Access Carotid Artery Stenting Using the Neuroguard IEP System (PERFORMANCE III)

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 178 participants.

Also called NCT05845710

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 178 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT05845710
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United States, France (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05845710. Allocation not applicable; no masking; primary purpose treatment. Start 2023-10-05 (actual); primary completion 2025-08-12 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Direct Access Carotid Artery Stenting Using the Neuroguard IEP System (PERFORMANCE III)
Condition
Carotid Stenosis
Condition
Carotid Artery Diseases
Intervention (Device)
Neuroguard IEP Direct System
Lead sponsor
Contego Medical, Inc. (class: industry)
Collaborator
Yale Cardiovascular Research Group (class: other)
Collaborator
CardioMed Device Consultants, LLC (class: industry)
Collaborator
Advance Research Associates (class: other)
Collaborator
iMedNet (class: not stated)
Collaborator
AG Mednet (class: industry)

Record details

Record id
cardio:ct-nct05845710
Content hash
3365a51b58127310137bc5681a86eed046bc4d912de51443f16f78ad71965eef